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Epigenetic silencing involving the aberrant methylation of promoter region CpG islands is widely recognized as a tumor suppressor silencing
mechanism in cancer. However, the molecular pathways underlying aberrant DNA methylation remain elusive. Recently we showed that, on a
genome-wide level, CpG island loci differ in their intrinsic susceptibility to aberrant methylation and that this susceptibility can be predicted based on
underlying sequence context. These data suggest that there are sequence/structural features that contribute to the protection from or susceptibility to
aberrant methylation. Here we use motif elicitation coupled with classification techniques to identify DNA sequence motifs that selectively define
methylation-prone or methylation-resistant CpG islands.Motifs common to 28methylation-prone or 47methylation-resistant CpG island-containing
genomic fragments were determined using the MEME and MAST algorithms (http://meme.sdsc.edu). The five most discriminatory motifs derived
from methylation-prone sequences were found to be associated with CpG islands in general and were nonrandomly distributed throughout the
genome. In contrast, the eight most discriminatory motifs derived from the methylation-resistant CpG islands were randomly distributed throughout
the genome. Interestingly, this latter group tended to associate with Alu and other repetitive sequences. Used together, the frequency of occurrence of
these motifs successfully discriminated methylation-prone and methylation-resistant CpG island groups with an accuracy of 87% after 10-fold cross-
validation. The motifs identified here are candidate methylation-targeting or methylation-protection DNA sequences.
© 2005 Elsevier Inc. All rights reserved.Keywords: Epigenetics; DNA methylation; Discriminant analysis; Classification techniques; Repetitive DNA; AluIntroduction
CpG islands are short stretches (500–2000 bp) of genomic
DNA enriched for the dinucleotide, 5′-CpG-3′, which is the
substrate for methylation by DNA methyltransferases. While
most CpG sites in the human genome are methylated, those in
CpG islands are typically unmethylated in normal tissue. In
human cancers, de novo methylation of CpG island sequences is
accompanied by gene silencing and can serve as an alternative
to mutation or deletion in the inactivation of tumor suppressor
and other genes. Examples include the VHL gene in renal cell
carcinomas [1], the RB gene in retinoblastomas [2], the cell⁎ Corresponding author.
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doi:10.1016/j.ygeno.2005.12.016cycle inhibitor CDKN2A in many epithelial cancers [3], the
mismatch repair gene MLH1 in sporadic colon cancer [4], and
CDH1 in breast, bladder, and prostate cancer [5]. In the case of
CDH1, it has been demonstrated that monoallelic loss due to
methylation-induced silencing provides the second genetic “hit”
in hereditary gastric cancer [6]. Thus, aberrant methylation of
CpG islands plays a critical role in the initiation and progression
of cancer.
At present, it is not knownwhy someCpG islands succumb to
aberrant methylation during tumor progression while others are
protected from it. One possibility is that local sequence features
contribute to the susceptibility to, or protection from, de novo
methylation. For example, there is evidence to suggest that
methylation can spread from repetitive DNA [7,8,9]. Unusual
DNA structures (e.g., non-B-DNA) are also suggested to serve
as targets of de novo methylation [10,11]. Alternatively, methyl-
ation may be mistargeted in cancer cells through physical
interaction of DNA methyltransferases with sequence-specific
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Sp1-binding sites have been demonstrated to protect the murine
APRT promoter from methylation [14,15]. Finally, there is
mounting evidence that DNA-binding factors which function in
the organization of chromatin domains, such as CTCF, also play
a role in determining methylation status at imprinted genes and
other loci [16–20]. Collectively, these studies suggest that there
are local features which act in cis to influence the establishment
and/or stability of DNA methylation patterns. The identification
of such factors and their function will lead to a better under-
standing the molecular mechanisms underlying altered DNA
methylation patterning in aging and carcinogenesis.
Using a human cell culture model in which de novo methyl-
ation of CpG islands is driven by ectopic expression of DNMT1
[21], we recently showed that CpG island loci differ in their
innate susceptibility to de novo methylation [22]. By applying
DNA pattern recognition and supervised learning techniques,
we found that methylation-prone and methylation-resistant
CpG islands could be distinguished based on their underlying
sequence context [22]. These data demonstrated that there is a
sequence signature associated with susceptibility to, or protec-
tion from, aberrant methylation, at least as it occurs in the
DNMT1 overexpression model. We now extend these studies
in an initial attempt toward identifying cis-acting elements that
influence the propensity for aberrant DNA methylation. Using
a combined approach coupling motif elicitation to define DNA
patterns and classification techniques, we identified a sequence
signature based on the frequency of 13 DNA motifs that can
discriminate methylation-prone or methylation-resistant CpG
islands. It is hypothesized that these motifs may play a role in
the local susceptibility of CpG islands to aberrant DNA
methylation.
Results
Methylation-prone and methylation-resistant CpG island data
sets
In a previous study, we determined the methylation state of
1749 CpG islands in human fibroblasts clones overexpressing
the DNA methyltransferase, DNMT1, using restriction land-
mark genomic scanning (RLGS) [22]. Methylation-prone (MP)
loci were defined as those sequences that were consistently
hypermethylated in 3 of 3 independent DNMT1 overexpressing
clones but were never methylated in 3 vector-only control
clones. Methylation-resistant (MR) CpG islands were defined as
those that were never methylated in all 6 cell clones. The 4000-
bp genomic sequence circumscribing the CpG island center
(2000 bp upstream and 2000 bp downstream) was determined
for 28 MP and 47 MR CpG islands for which sequence infor-
mation was available. These functionally defined CpG island
fragments were used in motif analysis.
Motif discovery
To identify motifs associated with methylation susceptibility,
we derived sequences common to the methylation-prone or themethylation-resistant CpG islands using the program, MEME
(http://meme.sdsc.edu) [23]. MEME derives sequence motifs
from a training set of sequences and builds a position-specific
scoring matrix wherein there is a probability associated with
the occurrence of each base at each position. Twenty-eight
methylation-prone or 47 methylation-resistant CpG island se-
quences (4 kb centered on the CpG island; see Ref. [22]) were
used as input into the MEME algorithm, and the first 20 “best-
fit” motifs were obtained for each data set.
These 40 motifs were then individually aligned to the entire
data set of 75 sequences with the motif alignment program,
MAST (http://meme.sdsc.edu) [24] to determine the number
of occurrences of each motif in the methylation-prone and
methylation-resistant data sets. Only those motif hits with a
position-specific goodness-of-fit P value of less than 10e-6 were
considered. A t test was then used to compare the frequency of
each motif between methylation-prone and methylation-resis-
tant CpG island data sets. Motifs with frequencies that were
not significantly different between the methylation-prone and
methylation-resistant groups (P N 0.01) were excluded from
further analyses. This primary filter yielded 8 motifs derived
from the methylation-resistant sequences (MR) and five motifs
derived from the methylation-prone sequences (MP) (Table 1).
The spatial positions of these 13motifs within the CpG islands in
both data sets are shown in Figs. 1 and 2, and the number of
occurrences is listed in Table 1. The position-specific scoring
matrices of these motifs are available as Supplemental Data and
can be used to probe any DNA sequence set using MAST.
Motif frequencies in the human genome
We next examined the more global distribution of the motifs
in CpG island and non-CpG island DNA. To accomplish this,
we extracted all 2348 annotated CpG islands from human
chromosome 1 (http://genome.ucsc.edu). The 4-kb CpG island
genomic fragments were constructed by locating the center
position of each CpG island and extracting 2000 bp of sequence
flanking both sides of this position. In a similar manner, a
control data set of 2348 random 4000-bp fragments was also
generated. The occurrences of the Mr and Mp motifs was then
determined in these data sets using MAST. The results in Table
2 show a strong association of methylation-prone motifs with
CpG islands in general relative to random DNA (t test;
P = 0.035). In contrast, the methylation-resistant motifs were
similarly distributed in both CpG island and non-CpG island
DNA (t test; P = 0.243). These data indicate that the MP motifs
are nonrandomly distributed in the genome and are selectively
associated with CpG island DNA. Interestingly, although ran-
domly distributed throughout the genome, there appeared to be
a strong association between the methylation-resistant motifs
and Alu sequences (Fig. 1B).
Methylation-prediction potential
Next we tested the potential of the 13 motifs to classify
methylation-prone and methylation-resistant CpG islands using
a linear-optimization-based discriminant analysis-supervised
Table 1
Summary of motif occurrences in 75 CpG island fragments
Motif Length
(bp)
Consensus sequence Methylation prone
(n = 28) a
Methylation resistant
(n = 47) b
t test
Sum μ σ Sum μ σ p c
MP-α 20 GGCTGCGGGGGCAGCAGCTG 32 1.1 0.8 13 0.3 0.6 5.06E-06
MP-β 21 AAGAAGGGAGAGAAGGAGGAA 35 1.3 0.9 14 0.3 0.5 7.34E-06
MP-γ 29 TCCTCTCCCTTGTCTTCCTCCTCCTCCTC 28 1.0 0.9 9 0.2 0.4 1.38E-04
MP-δ 21 GGGGTGGGGGAGGGGGAGGAG 35 1.3 0.9 26 0.6 0.9 2.07E-03
MP-ε 11 CTCTCCCAAGC 16 0.6 0.7 5 0.1 0.4 2.23E-03
MR-α 29 TTTTTTTTTTTTTTTTTGAGACAGAGTCT 7 0.3 0.4 58 1.2 1.2 2.87E-06
MR-β 15 GTCAGGAGTTTGAGA 2 0.1 0.3 35 0.7 0.9 1.63E-05
MR-γ 21 GCCCAGGCTGGAGTGCAGTGG 12 0.4 0.7 57 1.2 0.8 2.67E-05
MR-δ 37 GCCTGTAATCCCAGCTACTCAGGAGGCTGAGGCAGGA 12 0.4 0.6 54 1.1 1.3 1.66E-03
MR-ε 28 AAAGTGCTGGGATTACAGGCGTGAGCCA 6 0.2 0.5 33 0.7 0.8 2.19E-03
MR-ζ 29 CTCACTGCAACCTCCGCCTCCCGGGTTCA 21 0.8 0.8 66 1.4 0.9 2.67E-03
MR-η 21 TGATCCGCCCGCCTCGGCCTC 12 0.4 0.6 40 0.9 0.7 5.73E-03
MR-τ 21 CCAGCCTGGCCAACATGGTGA 9 0.3 0.7 38 0.8 0.9 8.52E-03
a Total number (Sum), mean (μ), and standard deviation (σ) of MAST hits (P b 10E-6) in 28 methylation-prone CpG island fragments (4000 bp).
b Total number (Sum), mean (μ), and standard deviation (σ) of MAST hits (P b 10E-6) in 47 methylation-prone CpG island fragments (4000 bp).
c Student's t test comparing the average number of MAST hits between the two CpG island classes.
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representing the number of occurrences of the 13 motifs is used
as the input variable to develop a predictive rule. Two strategies
were used to validate the method. In the first strategy, all 75 CpG
island sequences served as the data set and the performance was
estimated by 10-fold cross-validation. This analysis resulted in
the correct classification of 22 of 28 methylation-prone (79%)
and 41 of 47 (87%) methylation-resistant sequences, for an
overall rate of correct classification of 84%. The second strategy
was designed to gauge whether comparable rates of classifica-
tion are obtained when a smaller training set is used to generate
the rule. Fifteen methylation-prone and 15 methylation-resistant
sequences were randomly selected as the data set and the accu-
racy was estimated by 10-fold cross-validation. The rate of
correct classification was 79% for the methylation-prone and
94% for the methylation-resistant CpG islands. These same 30
sequences were then used as a training set to generate a classifier
which was then applied to the remaining 45 CpG islands that
had not been used in the training module. In this case, the rate
of correct classification was 79% for the methylation-prone
sequences and 81% for the methylation-resistant CpG islands.
The supervised learning approach is therefore quite reliable in
that by using less than half of the total sequences as the training
set, the predictive power is very close to the unbiased estimate.
The results of these validation tests suggest that a discriminant
function derived from this linear-optimization-based discrimi-
nant analysis method, and exploiting these 13 motifs, can be
expected to correctly predict sequences with an accuracy of
∼80%. In a final set of experiments, we used an unsupervised
approach (PAM) in which the feature vector representing the
number of occurrences of the 13 motifs was used as input to
directly classify the 75 CpG island sequences. In this case, the
sequences were classified with an accuracy of 93% (26 of 28
correct) for the methylation-prone and 79% (37 of 47 correct) for
the methylation-resistant sequences, for an overall rate of correct
classification of 84%. This correct classification rate is verysimilar to that obtained from the supervised learning method
above, reinforcing the discriminatory power of the 13 motifs.
Discussion
Gene silencing associated with aberrant methylation of pro-
moter region CpG islands is one mechanism leading to tumor
suppressor gene inactivation in human cancers. However,
whereas this is a common mechanism of inactivation of some
tumor suppressor genes (CDH1, MLH1, CDKN2A), there are
others (e.g., VHL, TP53, MSH2) that that although subject to
frequent genetic inactivation in cancer cells, are rarely affected
by such epigenetic silencing. In this study, we describe the
identification of sequence motifs that can reliably discriminate
CpG island loci with different propensities for de novo
methylation. Methylation-prone and methylation-resistant
sequences could be discriminated based on the frequency of
13 novel sequence motifs with an overall accuracy of 84–87% in
both supervised and unsupervised learning approaches. These
data add further support to the notion that there is a sequence
signature associated with the propensity toward aberrant
methylation. The identification of such factors may contain
clues to the mechanism of aberrant CpG island methylation that
accompanies aging and carcinogenesis.
In previous work, we showed that genomic loci differ in their
innate susceptibility to aberrant methylation and that the pro-
pensity toward this aberrant methylation could be predicted
based on the underlying sequence context. In that study, we
used pattern recognition and supervised learning to identify
short DNA sequence patterns that were capable of discriminat-
ing methylation-prone and methylation-resistant sequences with
an accuracy of ∼82% in blind predictions [22]. Seven DNA
patterns (TCCCCCNC; TTTCCTNC; TCCNCCNCCC; GG-
AGNAAG; GAGANAAG; GCCACCCC; GAGGAGGNNG)
were selected as having the highest discrimination potential
between the two CpG island classes. Here we used a motif
Fig. 1. Spatial distribution of the 5 methylation-prone motifs in all 75 CpG island loci. MEME-derived position-specific probability matrices were used to
identify motifs occurrences in the methylation-prone (top) or methylation-resistant (bottom) CpG island fragments (4000 bp) using the MAST algorithm. In each
case the region encompassing the CpG island is indicated by a gray box. Methylation-prone (MP) motifs and Alu elements (Alu) are shown according to the
color legend.
575F.A. Feltus et al. / Genomics 87 (2006) 572–579elicitation protocol, MEME, to identify motifs associated with a
propensity toward aberrant methylation. The MEME algorithm
does not identify simple consensus sequences but rather derives
probability matrices wherein there is a probability associatedwith each base occurring at each position [23]. The sequence
motifs described here thus differ from the short sequence
patterns derived in our previous studies in that they are longer
(11–37 bp) and represent weighted probability matrices instead
Fig. 2. Spatial distribution of the 7 methylation-resistant motifs in all 75 CpG island loci. MEME-derived position-specific probability matrices were used to
identify motifs occurrences in the methylation-prone (top) or methylation-resistant (bottom) CpG island fragments (4000 bp) using the MAST algorithm. In each
case the region encompassing the CpG island is indicated by a gray box. Methylation-resistant (MR) motifs and Alu elements (Alu) are shown according to the
color legend.
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degree of sequence divergence. In addition, the motifs were
derived based on their selective association with either
methylation-prone or methylation-resistant sequences. Thisbecomes an important consideration as the factors that confer
susceptibility to, or protection from, aberrant methylation are
likely to be differentially represented in the two data sets. The
inclusion of sequence divergence and increased length of
Table 2
Motif frequencies on chromosome 1
Motif Length (bp) CpG Islands a Random DNAb Consensus sequence
MP-α 20 1234 100 GGCTGCGGGGGCAGCAGCTG
MP-β 21 1499 1221 AAGAAGGGAGAGAAGGAGGAA
MP-γ 29 1565 630 TCCTCTCCCTTGTCTTCCTCCTCCTCCTC
MP-δ 21 1907 468 GGGGTGGGGGAGGGGGAGGAG
MP-ε 11 164 60 CTCTCCCAAGC
MR-α 29 4630 6017 TTTTTTTTTTTTTTTTTGAGACAGAGTCT
MR-β 15 1450 1678 GTCAGGAGTTTGAGA
MR-γ 21 2664 2733 GCCCAGGCTGGAGTGCAGTGG
MR-δ 37 5144 6330 GCCTGTAATCCCAGCTACTCAGGAGGCTGAGGCAGGA
MR-ε 28 3062 3954 AAAGTGCTGGGATTACAGGCGTGAGCCA
MR-ζ 29 3709 3363 CTCACTGCAACCTCCGCCTCCCGGGTTCA
MR-η 21 4566 4626 TGATCCGCCCGCCTCGGCCTC
MR–τ 21 2685 3316 CCAGCCTGGCCAACATGGTGA
a MAST hits (P b 10E-6) to 2348 CpG island-centered 4000-bp fragments from chromosome 1.
b MAST hits (P b 10E-6) to 2348 randomly generated 4000-bp fragments from chromosome 1.
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of detecting biologically relevant DNA patterns. A similar
approach was recently used to discover a motif signature pre-
dictive of imprinted genes [28].
Several genetic elements have been proposed to contribute
tomethylation propensity [7–20,29,30]. For example, Hasse and
Schultz have shown that multiple fragments of the rat α-
fetoprotein gene conferred de novo methylation on a linked
reporter gene when transiently transfected into F9 mouse em-
bryonal carcinoma cells [31]. These regions all contained B1 and
B2 SINEs, the murine equivalent of primate Alu elements,
suggesting that repetitive DNA elements may serve as a nidus
from which methylation can spread [8]. Similarly, methylation
has been suggested to spread from human Alu repeats in
the CDH1 [7] and TP53 genes [9]. Interestingly, 5/8 of the
methylation-resistant motifs (MR-β, MR-τ, MR-δ, MR-ε, MR-ζ)
show homology to Alu sequences and clustered within bona fide
Alu elements surrounding the CpG islands (see Fig. 1B). These
data also are consistent with the our previous observation that
Alu elements are more frequently associated with the methyl-
ation-resistant than methylation-prone CpG islands [22]. The
functional significance of this association is not entirely
clear, but may reflect a selection against retrotransposition into
methylation-prone regions during the Alu expansion or differ-
ential rates of Alu loss through inter-Alu recombination events
[32].
Motifs associated with methylation propensity could also
represent binding sites for proteins involved in the promotion or
prevention of aberrant DNA methylation. It has been proposed
that mistargeting of DNA methyltransferases by association
with sequence specific transcription factors, such as RB [12] or
the PML-RAR [13] fusion protein created chromosomal
translocation in promyelocytic leukemias, could promote
aberrant methylation in cancer cells. Although the methyla-
tion-prone motifs derived here do not obviously resemble E2F
or RAR-binding sites, it remains formally possible that other
DNA-binding factors may be involved. Likewise, Sp1 sites
have been suggested to protect the APRT promoter from
methylation [14,15]. More recently, binding of the insulatorprotein CTCF has been shown to protect a linked transgene
from heterochromatin-mediated extinction and subsequent de
novo DNA methylation [33]. Indeed, the normal function of
CTCF appears to be the establishment of boundaries between
adjacent chromatin domains and the maintenance proper
imprinting at the H19-Igf2 locus [34]. CTCF binding to a
differentially methylated domain (DMD) upstream of the H19
gene is required to maintain the unmethylated state and proper
expression of the maternal H19 allele [16,17]. CTCF-binding
elements do not conform to a simple consensus owing to
differential usage of its 12 zinc fingers for DNA binding and
such sites must be determined empirically [35], so it is difficult
to predict whether any of the current methylation-resistant
motifs represent CTCF sites, but this is an area for further
investigation.
The idea that sequence context can influence aberrant
methylation does not necessarily indicate the involvement of a
sequence-specific binding factor. Alternatively, such motifs may
reflect a common DNA secondary structure that is important
methylation susceptibility, as suggested for the Fragile-X repeat
[10], and it may be that similar secondary structures can be
formed by dissimilar sequences. In this regard, the incorporation
of a method that allows for sequence divergence via the use of
motif profiles may be important for identifying structurally
conserved, but sequence-divergent elements.
It should be noted that the factors that influence susceptibility
to aberrant methylation in the DNMT1 overexpression model
are not necessarily the same as those that dictate de novo
methylation occurring in human cancers. Whether the motif
signature derived here will be more broadly applicable to se-
quences that are commonly methylated in cancer remains to be
determined. One complication with such studies is how to define
methylation propensity across cell types and systems. There
are some genes like GSTP1 and VHL which are frequently
methylated, but only in a single tumor type, and thus could be
considered methylation prone or resistant depending on the
situation. In this regard, it is noteworthy that the CpG islands that
are methylation prone in the DNMT1 overexpressionmodel tend
to correspond to those that are methylated in multiple tumor
578 F.A. Feltus et al. / Genomics 87 (2006) 572–579types rather than a tumor-type-specific manner in genome-wide
studies in human cancers [42]. Nevertheless, the methods
employed should be directly translatable to genome-wide CpG
island methylation data sets from the analysis of human tumors
(e.g., [42,43]). Our current efforts are focused on the identi-
fication of sequence features that reliably discriminate methyl-
ation-prone and -resistant CpG islands in tumor-type-specific
classifiers, as well as development of sequence-feature-based
algorithms for tumor classification.
In summary, a set of 13 novel sequence motifs derived
from methylation-prone or methylation-resistant CpG island
sequences were discovered. Only the methylation-prone motifs
were selectively associated with CpG islands, while the
methylation-resistant motifs appeared to be randomly distribut-
ed along chromosome 1, presumably due to their strong asso-
ciation with Alu elements. Together, these 13 motifs were able
to predict the methylation state of a CpG island ∼80% of the
time. This work represents a first-generation strategy to discover
candidate cis-acting methylation-susceptibility motifs using a
genome-scanning approach and their effect upon CpG island
methylation can be evaluated through transfection and trans-
genic approaches. A better understanding of the molecular
mechanisms of CpG methylation susceptibility will enhance our
ability to predict and possibly block epigenetic gene silencing in
cancer.
Materials and methods
Sequence data sets
Methylation-prone and methylation-resistant CpG islands were identified as
previously described [22]. Briefly, genome-wide CpG island methylation
profiles were generated by Restriction Landmark Genomic Scanning. This
technique is based on the two-dimensional separation of genomicNotI restriction
fragments. The methylation state for each CpG island was detected as the
presence or absence of DNA cleavage by the methylation-sensitive enzyme,
NotI, which is almost exclusively found in CpG islands [36]. Methylation-prone
CpG islands (66 total) were defined as those loci that were consistently
methylated in multiple DNMT1 overexpressing clones but not in vector-only
control clones. Methylation-resistant CpG islands were defined as those loci that
were never methylated in any clone. Using a NotI/EcoRV boundary library [37]
or an in silico restriction digest of chromosomal assemblies [38], sequence
information was obtained for 28 methylation-prone and 47 methylation-resistant
CpG islands. The extent of the CpG island was determined using the CpG report
algorithm (EMBOSS [39]) which defines a CpG island as a region N200 bp, with
a C + G content N60% and an observed over expected CpG frequency N0.6. For
each of the 75 CpG islands in the study, the center of the CpG island was
determined, and 2 kb of sequence information in either direction was extracted
from the Celera [40] and the Human Genome Project [41] databases to give a
uniform set of 4-kb sequence fragments centered on the CpG island.
Human chromosome 1 CpG islands were extracted from the July 2003
freeze of the human genome (http://genome.ucsc.edu). CpG island start–stop
positions (2348 total) were extracted from the UCSC annotations, and the center
of the annotated CpG island was determined. Two kilobases flanking each side
of the CpG island center was extracted using custom Perl scripts. A control data
set of 2348 randomly generated 4000-bp fragments was also extracted from
chromosome 1.
Motif discovery and classification
Twenty-eight methylation-prone or 47 methylation-resistant CpG island
fragments were used as input for MEME ([23]; http://meme.sdsc.edu). Twentybest-fit motifs were obtained for each sequence set using the ZOOPs model
with default parameters. The position-specific scoring matrix for each of the
40 motifs from both CpG island classes was then used to probe a database of
the 75 CpG island sequences (28 methylation prone/47 methylation resistant)
using the motif alignment program, MAST (http://meme.sdsc.edu) [24]. The
frequency and position of all motif hits with a goodness-of-fit (P b 0.000001)
were extracted from the MAST output file using custom Perl scripts. A
Student’s t test was used to compare the frequency of occurrence of each motif
between the methylation-prone and methylation-resistant data sets. Those
motifs whose mean frequencies were significantly different at a threshold of
P b 0.01 were selected for further analysis. Classification based upon
supervised or unsupervised learning approaches was performed as previously
described [22,25–27] and the accuracy of prediction was estimated by 10-fold
cross-validation.
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